Form 4: Ocular Therapeutix Executive Sells Shares
Insider Transaction (Form 4)
Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix, Inc, sold 1,897 shares of common stock on August 24, 2026 for $10.78 per share.
Summary
- Open-market sale: disposed of 1,897 Common Stock at $10.78 ($20,450) on August 24, 2026; holds 326,898 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $20,450 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sanjay Nayak — Officer (Chief Strategy Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Common Stock | 1,897 | $11 | $20.4K | 326,898 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (1,897 shares) |
Keywords
insider transaction, Form 4, OCUL, OCULAR THERAPEUTIX, INC, bearish, Sanjay Nayak
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.